🇺🇸 FDA
Drug

ezetimibe

Brand: EZETIMIBE AND SIMVASTATIN

approved

Quick answer

ezetimibe (EZETIMIBE AND SIMVASTATIN), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

Key facts

INN
ezetimibe
Brand
EZETIMIBE AND SIMVASTATIN
Route
ORAL
Formulation
TABLET
Originator
Amneal Pharmaceuticals

Related patents

patent

US 11744816

Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me

Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10912751

Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and me

Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10905736

Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism

Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9095515

Ezetimibe compositions

Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is ezetimibe?

ezetimibe (EZETIMIBE AND SIMVASTATIN), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for ezetimibe?

EZETIMIBE AND SIMVASTATIN is a marketed brand name for ezetimibe. Check FDA Drugs@FDA for the current US label holder.